RecruitingNot ApplicableNCT06743295

AI Noise Reduction in Phonak Hearing Aids

Evaluation of Artificial Intelligence Based Noise Reduction in Phonak Hearing Aid on Patients With Hearing Impairment and Cochlear Implants


Sponsor

Mayo Clinic

Enrollment

500 participants

Start Date

Apr 24, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

The purpose of this study is to determine if artificial intelligence- based noise reduction can offer objective improvement in hearing and speech perception for hearing impaired patients.


Eligibility

Min Age: 18 YearsMax Age: 110 Years

Inclusion Criteria3

  • Patients with hearing impairment not using hearing aids
  • Individuals with hearing impairment currently using hearing aids
  • Cochlear implant patients with a single-sided implant (using a hearing aid in the opposite ear)

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEDEEPSONIC™ Deep Sound Optimized Neural Integrated Chip Artificial intelligence-based noise reduction

Participants with hearing loss will be fitted with the Phonak Audéo Sphere™ Infinio (PAI) hearing aid with artificial intelligence (AI)-based noise reduction, which incorporates deep neural networks (DNN) technology to reduce background noise. Speech stimuli, presented at a comfortable level of approximately 60 dB SPL (like normal conversation), will be delivered via a loudspeaker positioned directly in front of the participant. They will be tested in 3 listening environments: quiet, moderate noise, high noise. Speech perception scores will be measured as a function of each hearing aid program setting: quiet setting, moderate noise, and advanced AI-based reduction for high noise.


Locations(1)

Mayo Clinic in Rochester

Rochester, Minnesota, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06743295


Related Trials